Chronic glomerular microangiopathy complicating metastatic carcinoma
Authors:
- Alden L. HostetterAHAlden L. Hostetter
- Raymond R. TubbsRTRaymond R. Tubbs
- Thomas ZieglerTZThomas Ziegler
- Gordon N. GephardtGGGordon N. Gephardt
- James T. McMahonJMJames T. McMahon
- Martin J. SchreiberMSMartin J. Schreiber
- 31 March 1987
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 18 (4) , 342-348
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Renal failure and hemolytic anemia associated with mitomycin C. A case reportCancer, 1985
- Microangiopathic hemolytic anemia, a frequent complication of mitomycin therapy in cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1984
- Mitomycin-associated renal failure. Case report and reviewArchives of internal medicine (1960), 1983
- Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.Journal of Clinical Pathology, 1983
- Hemolytic Uremic Syndrome and Metastatic MalignancySouthern Medical Journal, 1982
- Renal disease after mitomycin c therapyCancer, 1981
- Microangiopathic hemolytic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5-fluorouracilCancer, 1980
- Microangiopathic Hemolytic Anemia and CancerMedicine, 1979
- Chronic glomerular microangiopathy and metastatic carcinomaHuman Pathology, 1979
- Microangiopathic Hemolytic Anemia in Metastatic CarcinomaAnnals of Internal Medicine, 1973